每經(jing)AI快(kuai)訊(xun)，證券日報刊文指(zhi)出(chu)，中(zhong)(zhong)藥(yao)(yao)材(cai)(cai)天地網數據顯示(shi)，部分品(pin)種(zhong)如當(dang)歸、黨參、白術(shu)等年漲幅超100%，更(geng)有甚者超400%。一般情況，中(zhong)(zhong)藥(yao)(yao)材(cai)(cai)價(jia)格(ge)(ge)波(bo)動屬正(zheng)常(chang)(chang)現(xian)象，上(shang)游中(zhong)(zhong)藥(yao)(yao)材(cai)(cai)價(jia)格(ge)(ge)上(shang)漲，下(xia)游中(zhong)(zhong)成藥(yao)(yao)生產企業隨(sui)之會(hui)對(dui)終端產品(pin)提價(jia)。但(dan)是(shi)，隨(sui)著全國中(zhong)(zhong)成藥(yao)(yao)集(ji)采(cai)(cai)常(chang)(chang)態化進行，中(zhong)(zhong)藥(yao)(yao)材(cai)(cai)價(jia)格(ge)(ge)上(shang)漲壓縮企業利潤空(kong)間，或(huo)導致(zhi)集(ji)采(cai)(cai)中(zhong)(zhong)選(xuan)(xuan)藥(yao)(yao)品(pin)供(gong)應(ying)存在風(feng)險。對(dui)此，建議相(xiang)(xiang)關政府部門(men)及企業應(ying)密切關注中(zhong)(zhong)藥(yao)(yao)材(cai)(cai)價(jia)格(ge)(ge)異常(chang)(chang)上(shang)漲情況，不能任其影響集(ji)采(cai)(cai)的(de)進程。其一，監(jian)管部門(men)應(ying)盡快(kuai)對(dui)中(zhong)(zhong)藥(yao)(yao)材(cai)(cai)價(jia)格(ge)(ge)上(shang)漲進行調查并出(chu)臺相(xiang)(xiang)關措(cuo)施(shi)管控。其二，集(ji)采(cai)(cai)中(zhong)(zhong)選(xuan)(xuan)企業也要采(cai)(cai)取多元措(cuo)施(shi)，降低中(zhong)(zhong)藥(yao)(yao)材(cai)(cai)價(jia)格(ge)(ge)波(bo)動對(dui)企業正(zheng)常(chang)(chang)生產的(de)影響。其三，建立中(zhong)(zhong)藥(yao)(yao)材(cai)(cai)種(zhong)植、需求、價(jia)格(ge)(ge)監(jian)控機(ji)制。